pharma news today glp-1 obesity drug How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 GLP-1s and the Unintended Consequences

Cognitive Functioning/Dementia At least 5 studies (1 case-control, 1 cohort, 3 RCTs) discussed the role of GLP-1 agonists and their action in AD and dementia

This article examines the current understanding of allulose's effects on GLP-1 activity, explores potential metabolic benefits, and provides practical guidance for patients considering allulose alongside GLP-1-based therapies

Persistent activation of GLP-1 receptors in exocrine pancreatic cells may lead to localized hyperplasia in the exocrine pancreas, consequently accelerating the formation of dysplastic lesions and pancreatitis [64]

Further research found that after treatment with the anti-mouse GIPR antibody 2.63.1, hepatocellular microvesicular changes were reduced, and the associated lipid accumulation also declined

The fact is that even a wave of local competition may be more critical

and was previously employed at Novo Nordisk